These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: relationship to blood carnitine status. Hamed SA; Abdella MM Epilepsy Res; 2009 Sep; 86(1):32-41. PubMed ID: 19446440 [TBL] [Abstract][Full Text] [Related]
3. [L-carnitine in valproic acid-induced hyperammonemia]. Martín-del Rincón JP; Llompart-Pou JA; Ferreruela M; Velasco J Med Intensiva; 2014 Mar; 38(2):124-5. PubMed ID: 23017629 [No Abstract] [Full Text] [Related]
4. Two cases of valproic acid poisoning treated with L-carnitine. Chan YC; Tse ML; Lau FL Hum Exp Toxicol; 2007 Dec; 26(12):967-9. PubMed ID: 18375641 [TBL] [Abstract][Full Text] [Related]
9. A case of acute valproic acid poisoning treated successfully with L-carnitine. Papaseit E; Farré M; López MJ; Clemente C; Campodarve I Eur J Emerg Med; 2012 Feb; 19(1):57-8. PubMed ID: 22223129 [No Abstract] [Full Text] [Related]
10. [The decreased level of plasma carnitine in patients with epilepsy]. Belousova ED Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(6):106-110. PubMed ID: 28745680 [TBL] [Abstract][Full Text] [Related]
11. Severe acute hyperammonemia after brief exposure to valproate. Eubanks AL; Aguirre B; Bourgeois JA Psychosomatics; 2008; 49(1):82-3. PubMed ID: 18212182 [TBL] [Abstract][Full Text] [Related]
12. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation. Ono H Clin Exp Nephrol; 2019 Jan; 23(1):148-149. PubMed ID: 29679355 [No Abstract] [Full Text] [Related]